Table 4.
Normal weight 18.5 ≦ BMI<24 (n = 17 ) |
Overweight 24 ≦ BMI<27 (n = 15) | Obese 27 ≦ BMI (n = 13) |
p | |
---|---|---|---|---|
UDI-6 | ||||
Pre-treatment | 9.0 ± 3.7 | 8.4 ± 4.1 | 7.4 ± 3.1 | 0.519 |
Post-treatment | 3.9 ± 3.8 | 5.4 ± 3.6 | 3.4 ± 1.5 | 0.182 |
Difference | − 4.3 ± 4.0 | − 4.7 ± 4.6 | − 3.8 ± 3.5 | 0.689 |
P (intergroup) | 0.020 | 0.035 | 0.045 | |
IIQ-7 | ||||
Pre-treatment | 12.1 ± 6.0 | 10.3 ± 6.7 | 11.7 ± 7.4 | 0.771 |
Post-treatment | 5.4 ± 8.2 | 5.4 ± 5.7 | 5.5 ± 7.3 | 0.759 |
Difference | − 5.5 ± 7.9 | − 8.0 ± 8.7 | − 5.3 ± 7.8 | 0.808 |
P (intergroup) | 0.050 | 0.035 | 0.142 | |
OABSS | ||||
Pre-treatment | 9.2 ± 2.9 | 10.1 ± 2.8 | 10.3 ± 3.7 | 0.121 |
Post-treatment | 5.0 ± 4.0 | 6.1 ± 4.8 | 5.8 ± 3.7 | 0.540 |
Difference | − 3.9 ± 5.9 | − 4.3 ± 4.8 | − 4.4 ± 4.6 | 0.991 |
P (intergroup) | 0.016 | 0.033 | 0.015 | |
Micturition episodes | ||||
Pre-treatment | 10.8 ± 5.0 | 8.6 ± 3.8 | 9.7 ± 4.1 | 0.400 |
Post-treatment | 5.7 ± 3.7 | 7.3 ± 4.8 | 4.6 ± 1.7 | 0.350 |
Difference | − 4.6 ± 5.3 | − 2.9 ± 6.4 | − 6.8 ± 5.0 | 0.501 |
P (intergroup) | 0.023 | 0.281 | 0.039 | |
Nocturia episodes | ||||
Pre-treatment | 2.8 ± 2.1 | 3.4 ± 1.6 | 3.1 ± 1.9 | 0.746 |
Post-treatment | 1.6 ± 1.4 | 2.4 ± 1.6 | 1.5 ± 1.6 | 0.378 |
Difference | − 1.2 ± 1.1 | − 1.6 ± 1.3 | − 1.8 ± 2.0 | 0.264 |
P (intergroup) | 0.036 | 0.017 | 0.079 | |
Urgency episodes | ||||
Pre-treatment | 6.0 ± 4.6 | 5.5 ± 3.8 | 7.9 ± 6.2 | 0.455 |
Post-treatment | 2.4 ± 3.5 | 2.5 ± 3.1 | 1.8 ± 2.2 | 0.657 |
Difference | − 4.0 ± 5.2 | − 5.1 ± 5.7 | − 7.8 ± 6.0 | 0.301 |
P (intergroup) | 0.044 | 0.047 | 0.043 | |
Urinary incontinence episodes | ||||
Pre-treatment | 3.4 ± 4.7 | 2.3 ± 1.9 | 2.2 ± 1.5 | 0.418 |
Post-treatment | 0.6 ± 0.8 | 1.1 ± 1.3 | 0.8 ± 1.2 | 0.778 |
Difference | − 2.7 ± 13.0 | − 2.0 ± 1.9 | − 1.2 ± 2.4 | 0.810 |
P (intergroup) | 0.038 | 0.027 | 0.324 |
Data are presented as mean ± standard deviation or as number (percent) of patients.
UDI-6: the short form of the Urogenital Distress Inventory, IIQ-7: the short form of the Incontinence Impact Questionnaire, OABSS: overactive bladder symptom score.